Loading clinical trials...
Loading clinical trials...
1.1 To build a TCM diagnosis and treatment database for chronic stable CAD; 1.2 To summarize the pattern of TCM medicine used and the effect of the medication in chronic stable CAD. 1.3 To formulate a syndrome differentiation determined medicine plan based on the improvement in the quality of life on chronic stable CAD patients.
Chronic stable coronary artery disease (SCAD) is a general term for all kinds of coronary artery disease (CAD) which includes patients with chronic stable angina, oldmyocardial infarctions and also stable condition after revascularization (i.e percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG)). According to 2012 American Heart Association/American College of Cardiology (AHA/ACC) guide, the objective of the treatment for SCAD is to maintain or recover patients' exercise tolerance, quality of life and avoid complication like heart failure,so as to decrease mortality, eliminate symptoms and avoid adverse reactions. Traditional Chinese medicine (TCM) has two thousand years of history in managing CAD and has its advantages in improving quality of life. Using scientific method to evaluate, demonstrate and conclude the clinical curative effect of TCM is an extremely important task for both TCM and Chinese and western integrative medicine win the treatment of CAD. Recent researches mainly focus on certain types or some certain pathological and physiological stages of CAD, worse still, different areas experts have their own experiences and opinions with the treatment. There is a lack of unified syndrome differentiation and prescriptions plan for the chronic stable CAD and not enough attention has been paid to TCM despite it having many advantages in improving quality of life in these patients. Considering all the above, this research studied past syndromes research results and real clinical effective chronic SCAD cases. Cases were analysed and explored, effective cases were filtered, syndrome differentiation of the prescriptions was refined, thus build a TCM diagnosis and treatment information database.
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Anhui, China
Beijing Hospital of Traditional Chinese Medicine
Beijing, China
Dongfang Hospital of Beijing University of Chinese Medicine
Beijing, China
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Beijing, China
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Beijing, China
the third Affiliated to Beijing University of Chinese Medicine
Beijing, China
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Beijing, China
Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Changchun, China
Affiliated Hospital of Gansu University of Chinese Medicine
Gansu, China
Guangdong Provincial Hospital of Chinese Medicine
Guangdong, China
Start Date
December 1, 2016
Primary Completion Date
December 1, 2017
Completion Date
December 1, 2017
Last Updated
January 13, 2017
2,000
ESTIMATED participants
Chinese Herb
DRUG
Lead Sponsor
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions